Amyotrophic lateral sclerosis in Sardinia (Italy): Epidemiologic features from 1957 to 2000

Acta Neurologica Scandinavica

Volumn 127, Issue 4, 2013, Pages 251-259

  Giagheddu, M ^a   Puggioni, G ^a   Tacconi, P ^a   Pirastru, M I ^b   Cannas, A ^a   Tamburini, G ^a   Congia, S ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Motor neuron diseases

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COMPARATIVE STUDY; DISEASE DURATION; FEMALE; HEALTH SURVEY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84875068360     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01705.x     Document Type: Article

References (64)

1. Holloway SM, Emery AEH. The epidemiology of motor neuron disease in Scotland. Muscle Nerve 1982;5:131-3.
2. Angelini C, Armani M, Bresolin N. Incidence and risk factors of motor neuron disease in the Venice and Padua districts of Italy, 1972-1979. Neuroepidemiology 1983;2:236-42.
3. Kahana E, Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 1984;41:157-60.
4. Murray TJ, Cameron J, Heffernan LP et al. Amyotrophic lateral sclerosis in Nova Scotia. Adv Exp Med Biol 1987;209:345-9.
5. Jokelainen M. Amyotrophic lateral sclerosis in Finland. Adv Exp Med Biol 1987;209:341-4.
6. Swingler RJ, Fraser H, Warlow CP. Motor neuron disease and polio in Scotland. J Neurol Neurosurg Psychiatry 1992;55:1116-20.
7. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry 1983;46:197-205.
8. Martyn CN, Barker DJP, Osmond C. Motor neuron disease and past poliomyelitis in England and Wales. Lancet 1988;i:1319-22.
9. Lilienfeld DE, Chan E, Ehland J et al. Rising mortality from motor neuron disease in the USA, 1962-84. Lancet 1989;i:710-2.
10. Stallones L, Kasarkis EJ, Stipanovich C, Snider G. Secular trends of mortality rates from motor neuron disease in Kentucky 1964-1984. Neuroepidemiology 1989;8:68-78.
11. Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 1989;39:768-73.
12. Flaten TP. Rising mortality from motor neuron disease. (letter). Lancet 1989;i:1118-1019.
13. Gunnarson LG, Lindberg G, Söderfeldt B, Axelson O. The mortality of motor neuron disease in Sweden. Arch Neurol 1990;47:42-6.
14. Dean G, Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry 1993;56:633-7.
15. Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology 1993;43:927-30.
16. Giagheddu M, Mascia V, Cannas A et al. Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study. Acta Neurol Scand 1993;87:446-54.
17. Dean G, Quigley M, Goldacre M. Motor neuron disease in a defined English population: estimate of incidence and mortality. J Neurol Neurosurg Psychiatry 1994;57:450-4.
18. Briani C, Marcon M, Dam M, Beghi E, Pegoraro E, Angelini C. Motor neuron disease in the Padua district of Italy: an epidemiological study. Neuroepidemiology 1996;15:173-9.
19. Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron mortality, 1969-1998. Neurology 2005;64:1215-21.
20. Altavista P, Belli S, Binazzi A et al. Increase in mortality for motoneuron disease in Italy, 1980-1999. Epidemiol Prev 2006;30:108-13.
21. Day TG, Scott M, Perring R, Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975-2004. Amyotroph Lateral Scler 2007;8:337-42.
22. Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 1994;241:448-55.
23. Guidetti D, Bondavalli M, Sabadini R et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996;15:301-12.
24. Seljeseth YM, Vollset E, Tysens OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 2000;55:1262-6.
25. Maasilta P, Jokelainen M, Löytönen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand 2001;104:232-5.
26. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand. A 22-year study. Neurology 2008;71:1889-95.
27. Fang F, Valdimarsdóttir U, Bellocco R et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol 2009;66:515-9.
28. Giagheddu M, Puggioni G, Masala C et al. Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand 1983;68:394-404.
29. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001;191:3-9.
30. Matias-Guiu J, Galan L, Garcia-Ramos R, Vela A, Guerrero A. Epidemiologia descriptiva de la sclerosis lateral amiotrophica. Neurologia 2007;22:368-80.
31. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997. Neurology 1999;52:504-9.
32. Piemonte and Valle d'aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001;56:239-44.
33. Govoni V, Granieri E, Capone J, Manconi M. Incidence of amyotrophic lateral sclerosis in the Local Health District of Ferrara, Italy, 1964-1998. Neuroepidemiology 2003;22:229-34.
34. Logroscino G, Beghi E, Zoccolella S et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005;76:1094-8.
35. Beghi E, Millul Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, The SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141-5.
36. O' Toole O, Traynor BJ, Brennan P et al. Epidemiology and clinical feature of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008;79:30-2.
37. Bonvicini F, Vincenti M, Marcello N, Rodolfi R, Rinaldi M. The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler 2008;9:350-3.
38. Marin B, Gill J, Preux P-M, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France. Amyotroph Later Scler 2009;10:216-20.
39. Chio' A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy. A 10-year prospective population based study. Neurology 2009;72:725-31.
40. Logroscino G, Traynor BJ, Hardiman O et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385-90.
41. Abhinav K, Stanton B, Johnston G et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. Neuroepidemiology 2007;29:44-8.
42. Gunnarsson LG, Palm R. Motor neuron disease and heavy manual labor: an epidemiologic survey of Värmland Country, Sweden. Neuroepidemiology 1984;3:195-206.
43. Martyn CN, Barker DJP, Swash M, Schwartz MS, Li TM. Trends in mortality from motoneuron disease (letter). Lancet 1989;333:958.
44. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. In: Roland LP, ed. Amyotrophic lateral sclerosis and other motor neuron diseases. New York: Raven Press, 1991; 245-70.
45. Bettoni L, Bazzani M, Bortone E, Dascola I, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960-1990. Acta Neurol Scand 1994;90:276-80.
46. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003;60:683-9.
47. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Manson TJ. Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 1983;33:911-5.
48. Editorial. What causes motor neuron disease? Lancet 1990;336:1033-5.
49. Strong M, Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler 2003;4:136-43.
50. Kalfakis N, Vassilopoulos D, Voumvourakis C, Ndjeveleka M, Papageorgiu C. Amyotrophic lateral sclerosis in Southern Greece: an epidemiologic study. Neuroepidemiology 1991;10:170-3.
51. Huber S, Henn V. Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zürich. Schweiz Archiv fur Neurol und Psychiatry 1995;146:52-4.
52. Bonaparte JP, Grant IA, Benstead TJ, Murray TJ, Smith M. ALS incidence in Nova Scotia over 20-year-period: a prospective study. Can J Neurol Sci 2007;34:69-73.
53. Gross-Paju K, Oöpik M, Lüüs SM et al. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand 1998;98:22-8.
54. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol 2007;254:866-9.
55. Jokelainen M, Palo J, Wikström J. The distribution of amyotrophic lateral sclerosis in Finland. J Neurol Sci 1975;25:473-9.
56. Hudson AJ, Davemport A, Hader WJ. The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada. Neurology 1986;36:1524-8.
57. Taylor JC, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989;42:569-75.
58. Scott KM, Abhinav K, Stanton BR et al. Geographic clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology 2009;32:81-8.
59. Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler 2004;5:208-12.
60. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A for the Registro Lombardo SLA (SLALOM). A Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25:114-9.
61. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on a ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258-61.
62. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-2.
63. Del Aguila MA, Longstreth WT, Mcguire V, Koepsell TD, Van Belle G. Prognosis in amyotrophic lateral sclerosis. A population based study. Neurology 2003;60:813-9.
64. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictor of prolonged survival. J Neurol 2006;253:1428-36.